GHTF Issues Guidance, Launches Pilot Program On Adverse Event Reporting
This article was originally published in The Gray Sheet
Executive Summary
An "Adverse Event Reporting Guidance" recently released by the Global Harmonization Task Force Study Group 2 could influence FDA to drop its requirement that manufacturers report adverse events even when they are foreseeable and appear in device labeling warnings.